SCHEMBL7130289

SCHEMBL7130289

O=C(Nc1ccc(NC(=O)c2cc([N+](=O)[O-])ccc2Cl)nc1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.66
MAPK1 P28482 3/20 0.66
PPARG P37231 3/20 0.66
CYP3A4 P08684 2/20 0.66
ALOX15 P16050 1/20 0.66
PPARA Q07869 1/20 0.66
RORC P51449 7/20 0.65
MAPT P10636 5/20 0.65
KMT2A Q03164 4/20 0.65
MEN1 O00255 3/20 0.65
TP53 P04637 2/20 0.65
LMNA P02545 1/20 0.65
CYP1A2 P05177 1/20 0.65
CYP2D6 P10635 1/20 0.65
CYP2C9 P11712 1/20 0.65
PKM P14618 1/20 0.65
TSHR P16473 1/20 0.65
NFKB1 P19838 1/20 0.65
CYP2C19 P33261 1/20 0.65
THPO P40225 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7118616 0.91 SMN1; SMN2 (0.67) SMN1; SMN2MAPK1PPARGCYP3A4ALOX15
SCHEMBL18147642 0.89 SMN1; SMN2 (0.61) SMN1; SMN2MAPK1PPARGCYP3A4ALOX15
SCHEMBL18147747 0.89 SMN1; SMN2 (0.64) SMN1; SMN2MAPK1PPARGCYP3A4ALOX15
SCHEMBL7129113 0.89 SMN1; SMN2 (0.67) SMN1; SMN2MAPK1PPARGCYP3A4ALOX15
SCHEMBL7119948 0.87 SMN1; SMN2 (0.83) SMN1; SMN2MAPK1PPARGCYP3A4ALOX15
SCHEMBL18146141 0.85 SMN1; SMN2 (0.62) SMN1; SMN2MAPK1PPARGCYP3A4ALOX15
SCHEMBL18147432 0.84 RORC (0.80) SMN1; SMN2MAPK1PPARGCYP3A4ALOX15
SCHEMBL7130609 0.84 RORC (0.84) SMN1; SMN2MAPK1PPARGCYP3A4ALOX15
SCHEMBL18146771 0.84 PPARG (0.61) SMN1; SMN2MAPK1PPARGCYP3A4ALOX15
SCHEMBL3936114 0.82 CYP1A2 (0.61) SMN1; SMN2MAPK1PPARGCYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD SMN1; SMN2 3743/4885MAPK1 231/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.